Cadrus Therapeutics, Inc. — Form D
Cadrus Therapeutics, Inc. of WORCESTER, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-20. The offering totals $500K, of which $40K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-05-20
- Form: D
- Accession: 0001464357-09-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $500K
- Amount sold: $40K
- Remaining: $460K
- Investors: 4
- Date of first sale: 2009-05-08
- Revenue range: Decline to Disclose
- SEC file number: 021-131373
Issuer
- Name: Cadrus Therapeutics, Inc.
- CIK: 0001464357
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2009
- Address: 67 MILLBROOK STREET, WORCESTER, MA, 01616
- Phone: (508) 842-7133
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| David Easson | Director | Worcester, MA |
| David Easson | Executive Officer | Worcester, MA |
More